Back
Innoviz Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
28
INVZ
Innoviz Technologies
Last Price:
0.93
Seasonality Move:
-14.86%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.06
Seasonality Move:
-0.9%
Sell
28
Innoviz Technologies (INVZ)
is a Sell
Is Innoviz Technologies a Buy, Sell or Hold?
- The current Innoviz Technologies [INVZ] share price is $0.96. The Score for INVZ is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- INVZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INVZ Stock Price Chart
What is Innoviz Technologies's stock price today?
-
The Innoviz Technologies share price today is $0.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INVZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
INVZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 44.81 | Sell |
| Chaikin Money Flow: | 730224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.92 - 1.08) | Sell |
| Bollinger Bands (100): | (1.03 - 1.51) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | 873891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Buy |
| Bollinger Bands (100): | (40.78 - 48.78) | Sell |
INVZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Buy |
| 20-day SMA: | 0.98 | Sell |
| 50-day SMA: | 1.07 | Sell |
| 200-day SMA: | 1.61 | Sell |
| 8-day EMA: | 0.93 | Buy |
| 20-day EMA: | 0.98 | Sell |
| 50-day EMA: | 1.09 | Sell |
| 200-day EMA: | 1.68 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.5 | Buy |
| 20-day SMA: | 40.58 | Buy |
| 50-day SMA: | 41.51 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 40.23 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 41.77 | Sell |
| 200-day EMA: | 43.33 | Sell |
Innoviz Technologies Earnings Growth & INVZ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.03 per share, an increase this year of $0.14 per share, and an increase next year of $0.11 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Innoviz Technologies Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||